Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
09/2014
09/23/2014US8841274 Protein arginine N-methyltransferase-5 method of cancer treatment
09/23/2014US8841260 Methods and compositions for treating Huntington's Disease
09/23/2014US8841256 P2X7: inhibition of epithelial cancers and papillomas
09/23/2014US8841255 Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides
09/23/2014US8841254 Method for treatment of anxiety
09/23/2014US8841251 Method for making a homogenous vaccine composition comprising a conjugate of EGF and 64K for the treatment of tumors
09/23/2014US8841250 Method for promoting muscle repair comprising administering G-CSF at the site of injury
09/23/2014US8841249 Growth hormones with prolonged in-vivo efficacy
09/23/2014US8841248 Manufacture of inter-alpha-inhibitor (IaIp) from plasma
09/23/2014US8841136 Levetiracetam immunoassays
09/23/2014US8841120 Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity
09/23/2014US8841110 Animal product free system and process for purifying a botulinum toxin
09/23/2014US8841083 PSA capture agents, compositions, methods and preparation thereof
09/23/2014US8840907 Isolated protein and compositions comprising the protein
09/23/2014US8840904 Compositions and methods for vaccinating against HSV-2
09/23/2014US8840903 Compositions and methods for vaccinating against HSV-2
09/23/2014US8840899 Use of mTOR inhibitors to enhance T cell immune responses
09/23/2014US8840889 Methods of modulating immune function
09/23/2014US8840886 Method of treating cancer with DLL4 antagonist and chemotherapeutic agent
09/23/2014CA2658231C Method of producing recombinant tat-hoxb4h protein for use as a stimulant of hematopoiesis in vivo
09/23/2014CA2646934C Methods for reducing protein aggregation
09/23/2014CA2621337C Cell-permeable peptide inhibitors of the jnk signal transduction pathway
09/23/2014CA2534474C Methods for treating cardiovascular disease using a soluble ctla4 molecule
09/23/2014CA2520271C Methods for the diagnosis and treatment of epilepsy
09/23/2014CA2483498C Generation of plants with improved pathogen resistance
09/23/2014CA2454822C Nucleic acids, polypeptides, and methods for modulating apoptosis using apoptosis-specific eif-5a
09/23/2014CA2441815C Method and composition for treatment of skeletal dysplasias
09/23/2014CA2378182C Compositions and methods for the treatment of tumors
09/23/2014CA2218225C Glucagon-like peptide-2 and its therapeutic use
09/18/2014WO2014145907A1 Targeting t cells with heterodimeric proteins
09/18/2014WO2014145755A1 Polyalkylene oxide valerate hemoglobin conjugates
09/18/2014WO2014145554A2 Novel green fluorescent protein (gfp) peptides
09/18/2014WO2014145441A1 Sortase-mediated protein purification and ligation
09/18/2014WO2014145408A1 Clinical methods for determining hiv-1 receptor tropism and cellular reservoirs of hiv-1 replication
09/18/2014WO2014145355A1 Composition comprised of antigen linked to a tnf superfamily ligand
09/18/2014WO2014145275A1 Methods for treatment of nephrotic syndrome and related conditions
09/18/2014WO2014145252A2 Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy
09/18/2014WO2014145245A2 Methods and compositions for norovirus blockade epitopes
09/18/2014WO2014145174A1 Immunogenic human rhinovirus (hrv) compositions
09/18/2014WO2014145065A1 Affinity-based analytical purification of biotherapeutcs for bioprocess monitoring
09/18/2014WO2014144903A1 Myostatin antagonism in human subjects
09/18/2014WO2014144842A2 Pharmaceutical compositions
09/18/2014WO2014144686A1 Compunds for treating neurodegenerative proteinopathies
09/18/2014WO2014144658A1 Dual reactivity potent kunitz inhibitor of fibrinolysis
09/18/2014WO2014144594A1 Toxoid, compositions and related methods
09/18/2014WO2014144521A1 Mitochondrial-derived peptide mots3 regulates metabolism and cell survival
09/18/2014WO2014144303A1 Fusion proteins and methods for identifying bromodomain inhibiting compounds
09/18/2014WO2014144229A1 Methods and compositions for dual glycan binding aav vectors
09/18/2014WO2014144148A1 Stabilized sos1 peptides
09/18/2014WO2014143884A2 Synthetic methylmalonyl-coa mutase transgene for the treatment of mut class methylmalonic acidemia (mma)
09/18/2014WO2014143701A1 Chemical crosslinkers
09/18/2014WO2014143087A1 Peptide vaccine for prevention and immunotherapy of dementia of the alzheimer's type
09/18/2014WO2014142764A1 New stable pentadecapeptide salts, a process for preparation thereof, a use thereof in the manufacture of pharmaceutical preparations and a use thereof in therapy
09/18/2014WO2014142647A1 Fungals strains with improved citric acid and itaconic acid production
09/18/2014WO2014142357A1 Treating agent for plant cell walls, substance delivery method using treating agent, and substance delivery system
09/18/2014WO2014142102A1 Liquid aqueous composition
09/18/2014WO2014141877A1 Tissue repair material
09/18/2014WO2014141683A1 Kntc2 peptides and vaccines containing the same
09/18/2014WO2014141244A1 Synthetic peptides for the treatment of autoimmune diseases
09/18/2014WO2014141176A1 Improved poxviral vaccines
09/18/2014WO2014140586A2 Mutant proteins and methods for their production
09/18/2014WO2014140504A1 Bone substitutes grafted by mimetic peptides of human bmp-2 protein
09/18/2014WO2014140366A1 New polypeptides
09/18/2014WO2014140333A1 Methods of treating colorectal cancer
09/18/2014WO2014140222A1 Pegylated glucagon and glp-1 co-agonists for the treatment of obesity
09/18/2014WO2014140210A1 Novel binding proteins for pcsk9
09/18/2014WO2014140190A1 Rsv vaccines
09/18/2014WO2014140113A1 Methods for treating and/or limiting development of diabetes
09/18/2014WO2014140083A1 Heat-stable respiratory syncytial virus prefusion f protein oligomers and their use in immunological compositions
09/18/2014WO2014139672A1 Her2/neu cancer vaccine
09/18/2014WO2014139587A1 Improved poxviral vaccines
09/18/2014WO2014138983A1 Novel cell wall deconstruction enzymes of malbranchea cinnamomea, thielavia australiensis, and paecilomyces byssochlamydoides, and uses thereof
09/18/2014WO2014138937A1 A growth hormone secretagogue receptor based protein, nucleic acids and methods and uses thereof
09/18/2014WO2014138924A1 Compositions and methods for treating clostridium difficile-associated diseases
09/18/2014WO2014138921A1 Enhanced liquid formulation stability of erythropoietin alpha through purification processing
09/18/2014WO2014138825A1 Immunogenic compositions and a process for producing same
09/18/2014WO2013091089A9 Three-dimensional cavities of dendritic cell immunoreceptor (dcir), compounds binding thereto and therapeutic applications related to inhibition of human immunodeficiency virus type-1 (hiv-1)
09/18/2014US20140275497 Methods for Making Cytokine Compositions From Tissues Using Non-Centrifugal Methods
09/18/2014US20140275496 Isolation of factor h from fraction i paste
09/18/2014US20140275489 Apelin fusion proteins and uses thereof
09/18/2014US20140275487 Binding domains directed against gpcr:g protein complexes and uses derived thereof
09/18/2014US20140275479 Specific binding agents of human angiopoeitin-2
09/18/2014US20140275477 Modification and Compositions of Human Secretoglobin Proteins
09/18/2014US20140275228 Methods for treating denervation-induced muscle atrophy
09/18/2014US20140275227 Compositions and methods of altering cholesterol levels
09/18/2014US20140275218 Wound healing compositions and treatments
09/18/2014US20140275213 Methods and Compositions for Plant Pest Control
09/18/2014US20140274915 Methods of Use for Recombinant Human Secretoglobins
09/18/2014US20140274909 Anti-cd22 chimeric antigen receptors
09/18/2014US20140274908 Epigenetic biomarker adamts9 for diagnosis and prognosis of gastric cancer
09/18/2014US20140274906 Nd2 peptides and methods of treating neurological disease
09/18/2014US20140274904 Inhibitors of mitochondrial fission and methods of use thereof
09/18/2014US20140274901 Proanp compositions and methods for treating acute heart failure
09/18/2014US20140274898 Hair growth methods using fgfr3 extracellular domains
09/18/2014US20140274885 PHI-4 Polypeptides and Methods For Their Use
09/18/2014US20140274883 Novel antiviral compounds from marine extracts
09/18/2014US20140274880 Mosquitocidal xenorhabdus, lipopeptide and methods
09/18/2014US20140274874 Variants of tissue inhibitor of metalloproteinase type three (timp-3), compositions and methods
09/18/2014US20140274812 Methods of Transcription Activator Like Effector Assembly
09/18/2014US20140274808 Digital to biological converter
1 ... 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 ... 2916